Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes.
Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes.
复制标题
DOI:
10.1111/exd.13378
复制
发表时间:
2017-11
影响因子:
3.6
通讯作者:
Krueger JG
中科院分区:
文献类型:
--
作者:
Fuentes-Duculan J;Bonifacio KM;Hawkes JE;Kunjravia N;Cueto I;Li X;Gonzalez J;Garcet S;Krueger JG
Psoriasis is a common immune-mediated disease that affects 2–4% of individuals in North America and Europe. In the past decade, advances in research have led to an improved understanding of immune pathways involved in the pathogenesis of psoriasis and has spurred the development of targeted therapeutics. Recently, three psoriasis autoantigens have been described: cathelicidin (LL-37), a disintegrin and metalloprotease domain containing thrombospondin type 1 motif-like 5 (ADAMTSL5), and lipid antigens generated by phospholipase A2 group IVD (PLA2G4D). It is important to establish the expression, regulation, and therapeutic modulation of these psoriasis autoantigens. In this study, we performed immunohistochemistry and two-color immunofluorescence on non-lesional and lesional psoriasis skin to characterize ADAMTSL5 and LL-37, and their co-expression with CD3+ T-cells, CD11c+ dendritic cells, and CD163+ macrophages, which are the main immune cells that drive this disease. Our results showed that ADAMTSL5+ and LL37+ cells are significantly (p<0.05) increased in lesional skin and are co-expressed by many dendritic cells, macrophages, and some T-cells in the dermis. Gene expression analysis showed significant (p<0.05) upregulation of LL-37 in lesional skin and significant downregulation following treatment with etanercept. ADAMTSL5+ and LL37+ cells are also significantly decreased by IL-17 or TNFα blockade, suggesting feed-forward induction of psoriasis autoantigens by disease-related cytokines.
登录
查看更多内容
DOI:
10.1084/jem.21213insight3
发表时间:
2015-12-14
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Krueger JG
通讯作者:
Krueger JG
影响因子:
6.5
作者:
Morizane, Shin;Yamasaki, Kenshi;Muehleisen, Beda;Kotol, Paul F.;Murakami, Masamoto;Aoyama, Yumi;Iwatsuki, Keiji;Hata, Tissa;Gallo, Richard L.
通讯作者:
Gallo, Richard L.
影响因子:
4.8
作者:
Chiba, H;Michibata, H;Imai, Y
通讯作者:
Imai, Y
影响因子:
--
作者:
GUBNER, R
通讯作者:
GUBNER, R
影响因子:
30.5
作者:
通讯作者:
--